Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?

When investing in a dividend stock, it's important to consider not just the yield, but also the potential for dividend growth and overall risk.

Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?

Published September 22, 2026 · Category: Finance

Overview

Picking a solid dividend stock to own for the long haul isn't necessarily easy. Balancing safety and dividend income can make it challenging to find the right stock to own, one that offers a fairly high yield, which isn't too risky. If the dividend is likely to grow in value is also an important consideration, as that can give investors an incentive to buy and hold.

Two intriguing dividend stocks that can be appealing options to investors today are Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE). The former has been raising its dividend at a high rate for years, while the latter has an incredibly high yield. Which one is the best option for dividend investors today?

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.